Daratumumab, a novel therapeutic human CD38 monoclonal antibody, effectively induces killing of multiple myeloma and other hematological tumors

Translated title of the contribution: Daratumumab, a novel therapeutic human CD38 monoclonal antibody, effectively induces killing of multiple myeloma and other hematological tumors

M. de Weers, J.M. Bakker, T. Vink, D.C.H. Jacobs, L.A. Oomen, W.K. Bleeker, J.G.J. van de Winkel, P.W.H.I. Parren, Y-T Tai, K.C. Anderson, M. Peipp, T. Valerius, J.W. Slootstra, H.M. Lokhorst

Research output: Contribution to conferenceAbstractOther research output

Translated title of the contributionDaratumumab, a novel therapeutic human CD38 monoclonal antibody, effectively induces killing of multiple myeloma and other hematological tumors
Original languageUndefined/Unknown
Pages24-24
Number of pages1
Publication statusPublished - 2010
EventUnknown event -
Duration: 26 Aug 201430 Aug 2014

Conference

ConferenceUnknown event
Period26/08/1430/08/14

Cite this